Uniqure NV
NASDAQ:QURE

Watchlist Manager
Uniqure NV Logo
Uniqure NV
NASDAQ:QURE
Watchlist
Price: 19.75 USD -1.94%
Market Cap: 1.2B USD

Wall Street
Price Targets

QURE Price Targets Summary
Uniqure NV

Wall Street analysts forecast QURE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for QURE is 57.03 USD with a low forecast of 30.3 USD and a high forecast of 99.75 USD.

Lowest
Price Target
30.3 USD
53% Upside
Average
Price Target
57.03 USD
189% Upside
Highest
Price Target
99.75 USD
405% Upside
Uniqure NV Competitors:
Price Targets
688428
InnoCare Pharma Ltd
59% Upside
ACLX
Arcellx Inc
57% Upside
PGEN
Precigen Inc
140% Upside
IKT
Inhibikase Therapeutics Inc
368% Upside
CHRS
Coherus BioSciences Inc
257% Upside
4593
Healios KK
128% Upside
URGN
Urogen Pharma Ltd
61% Upside
KALV
Kalvista Pharmaceuticals Inc
87% Upside

Revenue
Forecast

Revenue Estimate
Uniqure NV

The compound annual growth rate of Uniqure NV's revenue for the next 3 years is 96%.

N/A
Past Growth
96%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Uniqure NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Uniqure NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-46%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is QURE's stock price target?
Price Target
57.03 USD

According to Wall Street analysts, the average 1-year price target for QURE is 57.03 USD with a low forecast of 30.3 USD and a high forecast of 99.75 USD.

What is Uniqure NV's Revenue forecast?
Projected CAGR
96%

The compound annual growth rate of Uniqure NV's revenue for the next 3 years is 96%.

Back to Top